ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Acadia Pharmaceuticals INC.

Official 2024 U.S. DOL Form 5500 summary for Acadia Pharmaceuticals INC. (Acadia Pharmaceuticals 401(k) Plan And Trust · EIN 06-1376651 · PN 001): $142.50M net assets, 644 active participants, and Sponsor-paid or unbenchmarked.

Reported Form 5500 Fee & Service Summary

Plan SponsorAcadia Pharmaceuticals INC.
Filing IdentifierAcadia Pharmaceuticals 401(k) Plan And Trust · EIN 06-1376651 · PN 001
Plan Category & State401(k) Defined Contribution (CA)
Asset-Size Peer Cohort$100M-$500M
Plan Net Assets (2024)$142.50M
Active Participants644
Direct Admin Fee RateSponsor-paid or unbenchmarked
Cohort Peer MedianN/A
Primary Recordkeeper / ProviderResources Investment Advisors, LLC
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI